Header Logo

Connection

RAJKUMAR VENKATRAMANI to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Dose-Response Relationship, Drug.
RAJKUMAR VENKATRAMANI
Connection Strength
0.062
Dose-Response Relationship, Drug
  1. A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One. 2013; 8(7):e68416.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.